A detailed history of Nisa Investment Advisors, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 10,918 shares of MDXG stock, worth $104,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,918
Previous 11,161 2.18%
Holding current value
$104,048
Previous $77,000 16.88%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$5.65 - $7.76 $1,372 - $1,885
-243 Reduced 2.18%
10,918 $64,000
Q2 2024

Jul 19, 2024

BUY
$6.16 - $8.08 $579 - $759
94 Added 0.85%
11,161 $77,000
Q1 2024

May 01, 2024

BUY
$7.61 - $8.63 $1,133 - $1,285
149 Added 1.36%
11,067 $85,000
Q2 2023

Aug 11, 2023

SELL
$3.14 - $6.61 $4,144 - $8,725
-1,320 Reduced 10.79%
10,918 $72,000
Q4 2022

Feb 02, 2023

BUY
$2.63 - $3.45 $362 - $476
138 Added 1.14%
12,238 $34,000
Q3 2022

Nov 07, 2022

BUY
$2.71 - $4.22 $24,823 - $38,655
9,160 Added 311.56%
12,100 $33,000
Q2 2022

Aug 03, 2022

BUY
$3.17 - $5.0 $126 - $200
40 Added 1.38%
2,940 $10,000
Q1 2022

Apr 29, 2022

BUY
$4.27 - $6.27 $12,382 - $18,183
2,900 New
2,900 $14,000
Q2 2019

Jul 12, 2019

SELL
$2.37 - $5.57 $1,599 - $3,759
-675 Closed
0 $0
Q3 2018

Oct 16, 2018

SELL
$3.22 - $6.33 $2,189 - $4,304
-680 Reduced 50.18%
675 $4,000
Q2 2018

Jul 19, 2018

BUY
$5.39 - $8.96 $4,258 - $7,078
790 Added 139.82%
1,355 $9,000
Q1 2018

Apr 10, 2018

SELL
$6.69 - $17.96 $32,613 - $87,555
-4,875 Reduced 89.61%
565 $4,000
Q4 2017

Jan 12, 2018

SELL
$10.87 - $13.9 $5,435 - $6,950
-500 Reduced 8.42%
5,440 $69,000
Q3 2017

Oct 13, 2017

BUY
$11.86 - $17.34 $70,448 - $102,999
5,940
5,940 $71,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.08B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.